Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
CTAGE family member 3, pseudogene (CTAGE3P) is a processed pseudogene and not known to encode a functional protein. Although sometimes referenced with aliases similar to functional proteins or antigens (such as cTAGE-3 or cutaneous T-cell lymphoma-associated antigen 3), there is no evidence supporting its role as a therapeutic target, receptor, enzyme, transporter, or clinically actionable antigen. Pseudogenes like CTAGE3P may participate in gene regulation or serve as competitive endogenous RNAs, but current data do not show direct biological function or disease relevance for CTAGE3P specifically. It is classified as a non-coding element in the genome and not a canonical drug target or receptor. Its status as a pseudogene, and aliases overlapping with functional protein names, often leads to misidentification in research databases[5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on CTAGE family member 3, pseudogene (CTAGE3P).